KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer
Clinical trial NCT03925974 · COMPLETED
Trial details
- NCT number
- NCT03925974
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2022-05-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.